Anasazi Internal Medicine

Phoenix, Arizona 85032

0 studies enrolling now · 5 studies all time

What they study most

Combined Hyperlipidemia, Diabetes Mellitus, Type 2, Renal Insufficiency

Studies at this site

• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) — Completed
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes — Completed
• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia — Completed
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients — Stopped early